Search details
1.
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study.
Diabetes Obes Metab
; 23(7): 1505-1517, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33625777
2.
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.
Cardiovasc Drugs Ther
; 35(3): 549-559, 2021 06.
Article
in English
| MEDLINE | ID: mdl-32623598
3.
C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes.
Arterioscler Thromb Vasc Biol
; 39(11): 2402-2410, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31554419
4.
Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes.
Arterioscler Thromb Vasc Biol
; 39(2): 294-302, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30580572
5.
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Am Heart J
; 213: 57-65, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31108273
6.
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
J Thromb Thrombolysis
; 48(4): 563-569, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31512201
7.
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study.
Platelets
; 30(5): 579-588, 2019.
Article
in English
| MEDLINE | ID: mdl-29851527
8.
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome.
Am Heart J
; 187: 53-61, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28454808
9.
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
Am Heart J
; 178: 1-8, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-27502846
10.
Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.
Eur Heart J
; 36(29): 1901-12, 2015 Aug 01.
Article
in English
| MEDLINE | ID: mdl-25935875
11.
Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study.
Am Heart J
; 168(1): 96-102.e2, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24952865
12.
Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study.
Clin Chem
; 59(9): 1369-75, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23698074
13.
Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study.
Am Heart J
; 164(5): 728-34, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-23137503
14.
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.
Clin Chem
; 58(1): 190-9, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22126936
15.
SGLT2 inhibition reduces myocardial oxygen consumption.
Metabol Open
; 15: 100207, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36092797
16.
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study.
Int J Cardiol
; 365: 34-40, 2022 10 15.
Article
in English
| MEDLINE | ID: mdl-35842004
17.
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.
Front Physiol
; 13: 909870, 2022.
Article
in English
| MEDLINE | ID: mdl-35812313
18.
Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction.
Contemp Clin Trials Commun
; 19: 100629, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32875138
19.
Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial.
Eur Heart J Acute Cardiovasc Care
; 9(4): 313-322, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-31017470
20.
ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.
Atherosclerosis
; 293: 35-41, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31835039